The present invention provides particles for the presentation of haptens for
the purpose of eliciting an immune response. The amino acid sequences of the monomers
which make up the particles are derived from duck hepatitis B virus core protein.
The particles may also deliver nucleic acids. The nucleic acids may be delivered
for the purpose of enhancing an immune response, or for other purposes such as
gene therapy.
